List of Tables
Table 1. Inherited Metabolic Disorder Market Trends
Table 2. Inherited Metabolic Disorder Market Drivers & Opportunity
Table 3. Inherited Metabolic Disorder Market Challenges
Table 4. Inherited Metabolic Disorder Market Restraints
Table 5. Global Inherited Metabolic Disorder Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Inherited Metabolic Disorder Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Inherited Metabolic Disorder Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Inherited Metabolic Disorder Product Type
Table 9. Key Companies Time to Begin Mass Production of Inherited Metabolic Disorder
Table 10. Global Inherited Metabolic Disorder Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Metabolic Disorder as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Inherited Metabolic Disorder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Inherited Metabolic Disorder Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Inherited Metabolic Disorder Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Inherited Metabolic Disorder Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Inherited Metabolic Disorder Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Inherited Metabolic Disorder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Inherited Metabolic Disorder Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Inherited Metabolic Disorder Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Inherited Metabolic Disorder Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Inherited Metabolic Disorder Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Inherited Metabolic Disorder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Inherited Metabolic Disorder Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Inherited Metabolic Disorder Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Inherited Metabolic Disorder Sales Value by Region (2019-2024) & (%)
Table 27. Global Inherited Metabolic Disorder Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Inherited Metabolic Disorder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Inherited Metabolic Disorder Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Inherited Metabolic Disorder Sales Value, (2025-2030) & (US$ Million)
Table 31. Mayo Clinic Basic Information List
Table 32. Mayo Clinic Description and Business Overview
Table 33. Mayo Clinic Inherited Metabolic Disorder Products, Services and Solutions
Table 34. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Mayo Clinic (2019-2024)
Table 35. Mayo Clinic Recent Developments
Table 36. Angeion Corporation Basic Information List
Table 37. Angeion Corporation Description and Business Overview
Table 38. Angeion Corporation Inherited Metabolic Disorder Products, Services and Solutions
Table 39. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Angeion Corporation (2019-2024)
Table 40. Angeion Corporation Recent Developments
Table 41. Abbott U.S. Basic Information List
Table 42. Abbott U.S. Description and Business Overview
Table 43. Abbott U.S. Inherited Metabolic Disorder Products, Services and Solutions
Table 44. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Abbott U.S. (2019-2024)
Table 45. Abbott U.S. Recent Developments
Table 46. Admera Health Basic Information List
Table 47. Admera Health Description and Business Overview
Table 48. Admera Health Inherited Metabolic Disorder Products, Services and Solutions
Table 49. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Admera Health (2019-2024)
Table 50. Admera Health Recent Developments
Table 51. Promega Corporation Basic Information List
Table 52. Promega Corporation Description and Business Overview
Table 53. Promega Corporation Inherited Metabolic Disorder Products, Services and Solutions
Table 54. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Promega Corporation (2019-2024)
Table 55. Promega Corporation Recent Developments
Table 56. Alomone Labs Basic Information List
Table 57. Alomone Labs Description and Business Overview
Table 58. Alomone Labs Inherited Metabolic Disorder Products, Services and Solutions
Table 59. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Alomone Labs (2019-2024)
Table 60. Alomone Labs Recent Developments
Table 61. Bio-Rad Laboratories Basic Information List
Table 62. Bio-Rad Laboratories Description and Business Overview
Table 63. Bio-Rad Laboratories Inherited Metabolic Disorder Products, Services and Solutions
Table 64. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Bio-Rad Laboratories (2019-2024)
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Novartis AG Basic Information List
Table 67. Novartis AG Description and Business Overview
Table 68. Novartis AG Inherited Metabolic Disorder Products, Services and Solutions
Table 69. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Novartis AG (2019-2024)
Table 70. Novartis AG Recent Developments
Table 71. AstaReal Basic Information List
Table 72. AstaReal Description and Business Overview
Table 73. AstaReal Inherited Metabolic Disorder Products, Services and Solutions
Table 74. Revenue (US$ Million) in Inherited Metabolic Disorder Business of AstaReal (2019-2024)
Table 75. AstaReal Recent Developments
Table 76. Regeneron Pharmaceuticals Basic Information List
Table 77. Regeneron Pharmaceuticals Description and Business Overview
Table 78. Regeneron Pharmaceuticals Inherited Metabolic Disorder Products, Services and Solutions
Table 79. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Regeneron Pharmaceuticals (2019-2024)
Table 80. Regeneron Pharmaceuticals Recent Developments
Table 81. Biophytis Basic Information List
Table 82. Biophytis Description and Business Overview
Table 83. Biophytis Inherited Metabolic Disorder Products, Services and Solutions
Table 84. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Biophytis (2019-2024)
Table 85. Biophytis Recent Developments
Table 86. AbbVie Basic Information List
Table 87. AbbVie Description and Business Overview
Table 88. AbbVie Inherited Metabolic Disorder Products, Services and Solutions
Table 89. Revenue (US$ Million) in Inherited Metabolic Disorder Business of AbbVie (2019-2024)
Table 90. AbbVie Recent Developments
Table 91. Danone Basic Information List
Table 92. Danone Description and Business Overview
Table 93. Danone Inherited Metabolic Disorder Products, Services and Solutions
Table 94. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Danone (2019-2024)
Table 95. Danone Recent Developments
Table 96. Pfizer Basic Information List
Table 97. Pfizer Description and Business Overview
Table 98. Pfizer Inherited Metabolic Disorder Products, Services and Solutions
Table 99. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Pfizer (2019-2024)
Table 100. Pfizer Recent Developments
Table 101. Bristol Myers Squibb Basic Information List
Table 102. Bristol Myers Squibb Description and Business Overview
Table 103. Bristol Myers Squibb Inherited Metabolic Disorder Products, Services and Solutions
Table 104. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Bristol Myers Squibb (2019-2024)
Table 105. Bristol Myers Squibb Recent Developments
Table 106. Biogen Basic Information List
Table 107. Biogen Description and Business Overview
Table 108. Biogen Inherited Metabolic Disorder Products, Services and Solutions
Table 109. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Biogen (2019-2024)
Table 110. Biogen Recent Developments
Table 111. GSK plc Basic Information List
Table 112. GSK plc Description and Business Overview
Table 113. GSK plc Inherited Metabolic Disorder Products, Services and Solutions
Table 114. Revenue (US$ Million) in Inherited Metabolic Disorder Business of GSK plc (2019-2024)
Table 115. GSK plc Recent Developments
Table 116. Roche Holding AG Basic Information List
Table 117. Roche Holding AG Description and Business Overview
Table 118. Roche Holding AG Inherited Metabolic Disorder Products, Services and Solutions
Table 119. Revenue (US$ Million) in Inherited Metabolic Disorder Business of Roche Holding AG (2019-2024)
Table 120. Roche Holding AG Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Inherited Metabolic Disorder Downstream Customers
Table 124. Inherited Metabolic Disorder Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Inherited Metabolic Disorder Product Picture
Figure 2. Global Inherited Metabolic Disorder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 4. Inherited Metabolic Disorder Report Years Considered
Figure 5. Global Inherited Metabolic Disorder Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Inherited Metabolic Disorder Revenue in 2023
Figure 7. Inherited Metabolic Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Enzyme Replacement Therapy Picture
Figure 9. Cellular Transplantation Picture
Figure 10. Small Molecule Based Therapy Picture
Figure 11. Substrate Reduction Therapy Picture
Figure 12. Gene Therapy Picture
Figure 13. Drug Therapy Picture
Figure 14. Others Picture
Figure 15. Global Inherited Metabolic Disorder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Inherited Metabolic Disorder Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Hurler Syndrome
Figure 18. Product Picture of Niemann-Pick Disease
Figure 19. Product Picture of Tay-Sachs Disease
Figure 20. Product Picture of Gaucher Disease
Figure 21. Product Picture of Fabry Disease
Figure 22. Product Picture of Krabbe Disease
Figure 23. Product Picture of Others
Figure 24. Global Inherited Metabolic Disorder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Inherited Metabolic Disorder Sales Value Market Share by Application, 2023 & 2030
Figure 26. North America Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Inherited Metabolic Disorder Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Inherited Metabolic Disorder Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Inherited Metabolic Disorder Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Inherited Metabolic Disorder Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Inherited Metabolic Disorder Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Inherited Metabolic Disorder Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Inherited Metabolic Disorder Sales Value (%), (2019-2030)
Figure 37. United States Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 43. China Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 45. China Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 55. India Inherited Metabolic Disorder Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Inherited Metabolic Disorder Sales Value by Type (%), 2023 VS 2030
Figure 57. India Inherited Metabolic Disorder Sales Value by Application (%), 2023 VS 2030
Figure 58. Inherited Metabolic Disorder Industrial Chain
Figure 59. Inherited Metabolic Disorder Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
